American Medical Association. “Report 3 of the Council on Science and Public Health (I-09) Use of Cannabis for Medicinal Purposes (Resolutions 910, I-08; and 229, A-09),” amended 2009, available online at www.ama-assn.org.

American Medical Association. “Report 6 of the Council on Scientific Affairs (A-01) Full Report,” (2001), available online at www.ama-assn.org.

Arseneault L, et al. “Cannabis Use in Adolescence and Risk for Adult Psychosis,” BMJ (Nov. 23, 2002): Vol. 325, No. 7374, pp. 1212–13.

Caspi A, et al. “Moderation of the Effect of Adolescent-Onset Cannabis Use on Adult Psychosis by a Functional Polymorphism in the catechol-O-Methyltransferase Gene: Longitudinal Evidence of a Gene X Environment Interaction,” Biological Psychiatry (May 2005): Vol. 57, No. 10, pp. 1117–27.

Crippa JA, et al. “Cannabis and Anxiety: A Critical Review of the Evidence,” Human Psychopharmacology (Oct. 2009): Vol. 24, No. 7, pp. 515–23. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19693792

Grinspoon L, et al. Marijuana: The Forbidden Medicine (Yale University, 1997).

Iversen L. “Cannabis and the Brain,” Brain (June 2003): Vol. 126, No. 6, pp. 1252–70. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12764049

Iversen L. “Long-Term Effects of Exposure to Cannabis,” Current Opinion in Pharmacology (Feb. 2005): Vol. 5, No. 1, pp. 69–72. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15661628

Iversen LL. The Science of Marijuana, Second Edition (Oxford University Press, 2008).

Leweke FM, et al. “Cannabis and Psychiatric Disorders: It is Not Only Addiction,” Addiction Biology (June 2008): Vol. 13, No. 2, pp. 264–75. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18482435

Morgan CJ, et al. “Effects of Cannabidiol on Schizophrenia-Like Symptoms in People Who Use Cannabis,” The British Journal of Psychiatry (April 2008): Vol. 192, No. 4, pp. 306–07.

Murray RM, et al. “Cannabis, the Mind and Society: The Hash Realities,” Nature Reviews Neuroscience (Nov. 2007): Vol. 8, No. 11, pp. 885–95. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17925811

Patton GC, et al. “Cannabis Use and Mental Health in Young People: Cohort Study,” BMJ (Nov. 23, 2002): Vol. 325, No. 7374, pp. 1195–98.

Rey JM, et al. “Cannabis and Mental Health,” BMJ (Nov. 23, 2002): Vol. 325, No. 7374, pp. 1183–84.

Schierenbeck T, et al. “Effect of Illicit Recreational Drugs upon Sleep: Cocaine, Ecstasy and Marijuana,” Sleep Medicine Review (Oct. 2008): Vol. 12, No. 5, pp. 381–89. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18313952

Scuderi C, et al. “Cannabidiol in Medicine: A Review of its Therapeutic Potential in CNS Disorders,” Psychotherapy and Research (May 2009): Vol. 5, No. 1, pp. 69–72.

Strakowski SM, et al. “Effects of Co-Occurring Cannabis Use Disorders on the Course of Bipolar Disorder after a First Hospitalization for Mania,” Archives of General Psychiatry (Jan. 2007): Vol. 64, No. 1, pp. 57–64. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17199055

Wang T, et al. “Adverse Effects of Medical Cannabinoids: A Systematic Review,” Canadian Medical Association Journal (June 17, 2008): Vol. 178, No. 13, pp. 1669–78. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18559804

Watson SJ, et al. “Marijuana and Medicine: Assessing the Science Base: A Summary of the 1999 Institute of Medicine Report,” Archives of General Psychiatry (June 2000): Vol. 57, No. 6, pp. 547–52. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10839332

Zammit S, et al. “Self-Reported Cannabis Use as a Risk Factor for Schizophrenia in Swedish Conscripts of 1969: Historical Cohort Study,” BMJ (Nov. 23, 2002): Vol. 325, No. 7374, p. 1199.

Zuardi AW. “Cannabidiol: From an Inactive Cannabinoid to a Drug with Wide Spectrum of Action,” Revista Brasileira de Psiquiatria (Sept. 2008): Vol. 30, No. 3, pp. 271–80. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18833429

Zuardi AW, et al. “Cannabidiol Monotherapy for Treatment-Resistant Schizophrenia,” Journal of Psychopharmacology (Sept. 2006): Vol. 20, No. 5, pp. 683–86.

Zuardi AW, et al. “Cannabidiol, a Cannabis Sativa Constituent, As an Antipsychotic Drug,” Brazilian Journal of Medical and Biological Research (April 2006): Vol. 39, No. 4, pp. 421–29.